Review article Open access
Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. Although the majority of patients with CVD are treated with interventional procedures, a substantial number require medical therapy in terms of both prognosis and symptomatic relief. However, commonly used agents such as β-blockers an …